Journal of visualized experiments : JoVE · 2026
Workflow for Automated Digital Peripheral Blood and Bone Marrow Cytomorphology, With Consideration of Critical Cellular Misclassifications.
СтатьяVideo-Audio MediaПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Starostka David, Dolezilek Richard, Kvasnicka Hans Michael, Sotkovska Barbora, Miczkova Petra
Аннотация
Growing evidence supports the ability of AI-powered automated digital cytomorphology (ADM) of peripheral blood (PB) and bone marrow (BM) to assist expert decision-making. The ADM workflow for PB and BM smears is described. The core components of ADM technology include precision mechanics, advanced imaging systems, artificial intelligence (AI), and a user-friendly interface. The process begins with standardized smear preparation and staining using protocols adapted for automation and digitization. An automated microscope equipped with an immersion objective and digital camera captures high-resolution images of the specimen at multiple magnifications. AI-powered software then locates, records, and preliminarily classifies nucleated cells, including megakaryocytes when applicable. This is followed by mandatory expert review and, as needed, reclassification. Digital images and reports are subsequently stored on a high-capacity local server. Key benefits of ADM include increased speed, efficient data management, educational support, remote access for evaluation and consultation, digital archiving, and multimodal data integration. The most significant limitation of ADM is the risk of critical cellular misclassification, which can have a major clinical impact. Irrelevant misclassifications are tolerable and diagnostically neutral, whereas relevant misclassifications are unacceptable and may lead to serious diagnostic and clinical consequences. Critical misclassification of neoplastic lymphocytes, small lymphoblasts/myeloblasts, granular monoblasts, dysplastic promonocytes and monocytes, plasmablasts, and immature plasma cells-all of which may present with atypical morphology-carries a risk of misdiagnosis. Further advancements are required to achieve reliable diagnostic performance. Extensive, high-quality training data, combined with regular validation, are essential to ensure that AI functions as an effective supporting tool for diagnostic judgment.